TCM

TCG Crossover Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 698.5%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+698.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.03B
AUM Growth
+$1.16B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$64.7M
2
+$37.1M
3
+$27.7M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$27.6M
5
SYRE icon
Spyre Therapeutics
SYRE
+$17.9M

Top Sells

1
+$49M
2
+$15.6M
3
+$14.9M
4
UPB
Upstream Bio Inc
UPB
+$10.6M
5
THRD
Third Harmonic Bio
THRD
+$10.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KOD icon
26
Kodiak Sciences
KOD
$1.67B
$18.8M 0.92%
1,145,538
SYRE icon
27
Spyre Therapeutics
SYRE
$3.34B
$18.4M 0.91%
+1,100,582
SLN
28
Silence Therapeutics
SLN
$282M
$15.7M 0.77%
3,033,560
URGN icon
29
UroGen Pharma
URGN
$890M
$14.3M 0.7%
+717,347
ARVN icon
30
Arvinas
ARVN
$860M
$13.8M 0.68%
+1,617,365
MNPR icon
31
Monopar Therapeutics
MNPR
$357M
$12.5M 0.61%
+153,000
MBX
32
MBX Biosciences
MBX
$1.48B
$11.4M 0.56%
650,000
VTGN icon
33
VistaGen Therapeutics
VTGN
$23.6M
$9.5M 0.47%
2,676,580
RLAY icon
34
Relay Therapeutics
RLAY
$1.7B
$9.45M 0.46%
+1,810,351
ADVM
35
DELISTED
Adverum Biotechnologies
ADVM
$7.56M 0.37%
1,668,174
-128,308
AVTX icon
36
Avalo Therapeutics
AVTX
$333M
$6.14M 0.3%
483,000
ADCT icon
37
ADC Therapeutics
ADCT
$518M
$5.56M 0.27%
+1,390,175
PEPG icon
38
PepGen
PEPG
$449M
$5.54M 0.27%
+1,200,000
TRDA icon
39
Entrada Therapeutics
TRDA
$446M
$3.39M 0.17%
584,955
VTYX icon
40
Ventyx Biosciences
VTYX
$1B
$983K 0.05%
316,195
JBIO
41
Jade Biosciences
JBIO
$696M
– –
-64,023
CABA icon
42
Cabaletta Bio
CABA
$318M
– –
-86,795
CDTX
43
DELISTED
Cidara Therapeutics
CDTX
– –
-1,005,901
ELVN icon
44
Enliven Therapeutics
ELVN
$1.75B
– –
-498,000
KROS icon
45
Keros Therapeutics
KROS
$424M
– –
0
KURA icon
46
Kura Oncology
KURA
$755M
– –
-735,184
NKTR icon
47
Nektar Therapeutics
NKTR
$1.91B
– –
-266,666
SLNO icon
48
Soleno Therapeutics
SLNO
$2.1B
– –
-186,250
THRD
49
DELISTED
Third Harmonic Bio
THRD
– –
-1,915,424
1
2